Breast neuroendocrine neoplasm

Summary

Breast neuroendocrine neoplasm (MONDO:0002485) is a cancer. A subtype of neuroendocrine neoplasm — broader associated-gene and molecular evidence is on the parent page (see Disease family below).

At a glance

• Classification: Cancer

Clinical features

No curated clinical features (Orphanet) for this disease.

Identifiers

Disease identifiers

Field	Value
Canonical name	breast neuroendocrine neoplasm
Mondo ID	MONDO:0002485
DOID	DOID:3009
NCIT	C5169
UMLS	C1332635
MedGen	231969
GARD	0023146
Anatomy (UBERON)	UBERON:0000310
Is cancer (heuristic)	yes

Also known as: breast endocrine neoplasm · breast NET · breast neuroendocrine neoplasm · breast neuroendocrine tumor · breast neuroendocrine tumor, well differentiated, low or intermediate grade · breast neuroendocrine tumour · neuroendocrine neoplasm of breast · neuroendocrine neoplasm of the breast · neuroendocrine tumour of the breast

Data availability: 1 cell line.

Disease family

This is a subtype of neuroendocrine neoplasm. Genetic, therapeutic, and trial evidence is largely curated at the broader-term level — see the parent page for the associated-gene cohort and molecular evidence.

Classification path: disease › human disease › disease by etiologic mechanism › cancer or benign tumor › neoplastic disease or syndrome › neoplasm › endocrine gland neoplasm › neuroendocrine neoplasm › breast neuroendocrine neoplasm

Related subtypes (13): paraganglioma, neuroendocrine carcinoma, prostate neuroendocrine neoplasm, ovarian neuroendocrine neoplasm, carcinoid tumor, lung neuroendocrine neoplasm, laryngeal neuroendocrine neoplasm, middle ear neuroendocrine tumor, hereditary pheochromocytoma-paraganglioma, bronchial endocrine tumor, thymic neuroendocrine tumor, uterine corpus neuroendocrine neoplasm, digestive system neuroendocrine neoplasm

Subtypes (1): breast large cell neuroendocrine carcinoma

Genetics & variants

GWAS landscape

No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.

Variant details and genetic-evidence tiers

No tiered GWAS variants or ClinVar records for this disease.

Genes & proteins

No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).

Function

No pathway enrichment — requires an associated-gene cohort.

Therapeutics

No druggable-target or therapeutic data for this disease’s cohort.

Clinical trials & evidence

Clinical trials

Clinical trials: 0.